News

Etrion Corporation's Financial Update for Q3 2024 Results

Etrion Corporation's Financial Update for Q3 2024 Results

Etrion Corporation's Third Quarter Financial Results

Etrion Corporation has recently published its financial results for the third quarter of 2024, showcasing its financial position and recent activities.

Key Highlights from Q3 2024

As of the end of the third quarter of 2024, Etrion boasts an unrestricted cash balance of approximately US$7.1 million. Additionally, the company reports positive working capital amounting to US$6.5 million, indicating a healthier financial state.

Earn-out Payment Received

On September 30, 2024, Etrion's subsidiary in Luxembourg received an earn-out payment totaling US$1.2 million. This reimbursement relates to previous grid connection costs tied to an asset sold in Japan in 2021.

Sale of Permits in Japan

In addition to the earn-out payment, the Japanese subsidiary realized proceeds of US$0.2 million from the sale of certain permits and rights linked to a previously abandoned wind project.

Management's Outlook

During this quarter, Marco A. Northland, the Chief Executive Officer of Etrion, communicated that the company will proceed with a careful winding down of its operations. This decision aligns with earlier disclosures regarding its financial strategy and future actions.

Financial Summary

The financial data for Etrion presents a picture of recovery in certain areas, especially compared to prior performance metrics. Below are the summarized financial results:

Performance Overview

For the third quarter of 2024, Etrion reported a positive EBITDA of US$916,000, in stark contrast to a loss of US$806,000 in the same quarter last year. For the nine-month period, EBITDA was nearly stable, closing at US$18,000 compared to a loss of US$1.57 million in the previous year.

Net Income Analysis

The net income for the third quarter was US$338,000, reflecting significant improvement over the loss of US$1.26 million reported in Q3 2023. Over the nine-month span, the net income loss was US$744,000 as compared to a much larger loss of US$12.33 million in the prior year.

Financial Position Insights

Etrion's financial standing as of September 2024 shows unrestricted cash decreasing from US$9.92 million in December 2023 to US$7.14 million, and working capital has also seen a dip from US$7.58 million to US$6.5 million.

Assets and Resources

Total assets were recorded at US$7.38 million in September 2024, a decline from US$10.22 million the previous December. This shift indicates a transition in Etrion’s resource management as they adapt to their forthcoming business strategy and closure process.

About Etrion Corporation

Etrion's largest shareholder is the Lundin family, controlling around 36% of the company's shares either directly or through various trusts. This significant stake reflects a strong commitment to the company’s future direction and operational strategies.

Contact Information

For further inquiries, please reach out to:
Marco Northland – Chief Executive Officer and Chief Financial Officer
ceo-cfo@etrion.com

Frequently Asked Questions

What were Etrion's cash and working capital amounts?

As of Q3 2024, Etrion has an unrestricted cash balance of US$7.1 million and a positive working capital of US$6.5 million.

What significant payments did Etrion receive?

Etrion received an earn-out payment of US$1.2 million related to previously sold assets and additional proceeds of US$0.2 million from the sale of permits.

What is Marco Northland's comment on the company’s future?

Marco Northland indicated that the company will maintain limited resources and will proceed with a windup of the company operations as previously disclosed.

How did EBITDA change from last year?

EBITDA improved from a loss of US$806,000 in Q3 2023 to a positive US$916,000 in Q3 2024.

Who is Etrion's largest shareholder?

The Lundin family owns approximately 36% of Etrion's shares, demonstrating a significant commitment to the company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Arch Painting Champions Community Support at Major Event

Updated Category News Views 297

Arch Painting's Commitment to Community Support Arch Painting, a prominent entity in paint contracting services, is taking significant steps to support community initiatives. Recently, the company made headlines by becoming a Gold Sponsor of the Mobility Awareness Resource Community (M.A.R.C.) Network during a high-profile football event. The sponsorship highlights Arch...

Continue Reading
Radioligand Therapy Market Growth Forecast to $10.9 Billion

Updated Category News Views 300

Radioligand Therapy Market Growth and Future Outlook The global Radioligand Therapy (RLT) market is witnessing promising growth, with expectations to reach a valuation of USD 10.91 billion by the early 2030s, exhibiting a compound annual growth rate (CAGR) of 13.2% from 2025 onward. This significant progression can be attributed to the increasing number of approvals and...

Continue Reading
Boston Scientific Achieves Remarkable Growth in 2024 Earnings

Updated Category News Views 279

Introduction to Boston Scientific's 2024 Financial Triumph Boston Scientific Corporation (NYSE: BSX) has announced impressive results for the fourth quarter and the entire year of 2024. The figures indicate robust growth in net sales and earnings, underscoring the company's strong position in the medical technology sector. During the fourth quarter, net sales reached a...

Continue Reading
Top Tech Stocks to Watch: Momentum Indicators to Note

Updated Category News Views 190

Key Technology Stocks Exhibiting Momentum The information technology sector continues to capture the attention of investors, particularly those who prioritize momentum as a vital part of their trading strategies. In the rapidly evolving landscape of tech stocks, three companies have recently emerged as noteworthy players due to significant momentum indicators that may...

Continue Reading
Autoliv Exceeds Expectations as Key Stocks Surge on Friday

Updated Category News Views 55

Autoliv Reports Strong Third-Quarter Results On a recently mixed trading day for U.S. stocks, significant gains were noted with the Nasdaq Composite surging approximately 100 points. Among the noteworthy performers, shares of Autoliv, Inc. exhibited an impressive increase following the company’s announcement concerning its third-quarter financial performance. Key...

Continue Reading